"I would basically look at these 3 things as the major things to be coming up," says Jitesh Dhingra, MD, FRCEM.
Jitesh Dhingra, MD, FRCEM
Advertisement
Articles by Jitesh Dhingra, MD, FRCEM
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5
